U.S. Capital Wealth Advisors LLC Raises Stake in Danaher Co. (NYSE:DHR)

U.S. Capital Wealth Advisors LLC grew its holdings in Danaher Co. (NYSE:DHR) by 3.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,958 shares of the conglomerate’s stock after purchasing an additional 371 shares during the period. U.S. Capital Wealth Advisors LLC’s holdings in Danaher were worth $2,745,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also modified their holdings of DHR. AMF Tjanstepension AB acquired a new position in shares of Danaher in the 3rd quarter valued at $5,923,000. Czech National Bank lifted its stake in Danaher by 4.2% during the 3rd quarter. Czech National Bank now owns 130,939 shares of the conglomerate’s stock worth $36,404,000 after acquiring an additional 5,320 shares in the last quarter. GAMMA Investing LLC lifted its stake in Danaher by 33.5% during the 3rd quarter. GAMMA Investing LLC now owns 4,480 shares of the conglomerate’s stock worth $1,246,000 after acquiring an additional 1,125 shares in the last quarter. WealthBridge Capital Management LLC lifted its stake in Danaher by 51.8% during the 3rd quarter. WealthBridge Capital Management LLC now owns 1,465 shares of the conglomerate’s stock worth $407,000 after acquiring an additional 500 shares in the last quarter. Finally, Diversified Trust Co lifted its stake in Danaher by 29.6% during the 3rd quarter. Diversified Trust Co now owns 5,649 shares of the conglomerate’s stock worth $1,571,000 after acquiring an additional 1,289 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Trading Down 3.9 %

NYSE:DHR opened at $214.09 on Tuesday. The stock’s 50 day moving average price is $235.40 and its 200 day moving average price is $253.09. The company has a market capitalization of $154.64 billion, a PE ratio of 40.55, a P/E/G ratio of 2.80 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a 52-week low of $214.03 and a 52-week high of $281.70.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the firm posted $2.09 EPS. On average, research analysts anticipate that Danaher Co. will post 7.77 EPS for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were given a dividend of $0.27 per share. The ex-dividend date was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.50%. Danaher’s payout ratio is 20.45%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on DHR shares. Raymond James reissued a “market perform” rating on shares of Danaher in a research note on Monday. StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Stifel Nicolaus upped their price target on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Stephens restated an “overweight” rating and set a $315.00 price target on shares of Danaher in a report on Wednesday, October 23rd. Finally, Wells Fargo & Company cut their price target on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $278.00.

Insiders Place Their Bets

In other news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 10.90% of the stock is owned by insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.